Cell And Gene Articles, App Notes, Case Studies, & White Papers

31. Optimizing Kinetics Assays To Avoid Avidity Effects 1/31/2024

    Considering affinity and avidity early in assay design can ensure the desired assay parameters are achieved. Learn about affinity and avidity and how to recognize and resolve issues that may arise.

32. Development Strategies For Adenovirus-Based Gene Therapies 11/11/2024

    Scaling up viral vector production can be challenging, and ensuring consistent titers and activity requires careful optimization and technical expertise.

33. The Business Case For EHR eSource In Clinical Trials 4/12/2024

    Examine how manual data collection challenges prompted the adoption of an eSource solution that streamlined data entry, saving time and costs, reducing errors, and accelerating a multicenter phase 2 trial.

34. Transforming The Status Quo In Cell Therapy Manufacturing 5/29/2025

    Explore data-driven advancements in cell therapy manufacturing and learn how focusing on biology first can lead to more robust and scalable manufacturing solutions.

35. Innovative Therapeutic Applications Of Ion Exchange Resins 4/8/2025

    Chromatography resins are aiding in the delivery of cancer and inflammatory disease therapies. Learn how ion exchange resins act as therapeutic carriers for advanced drug delivery.

36. The Evolution Of AAV Production: Scaling Through Nature Instead Of Brute Force 5/28/2025

    This study evaluates the performance and productivity of VintaProcess in addressing the persistent manufacturing challenges in AAV gene therapy production.

37. Overcoming Challenges In AAV And LV Viral Vector Manufacturing 12/5/2023

    Manufacturing viral vectors leaves sponsors vulnerable to high costs, delays, and the possibility of failure. The right CDMO partner can help you reduce timelines and costs for viral vector production.

38. Monitoring And Determining The Cause Of Antibody Discoloration Using cIEF And EAD 9/21/2023

    View a study which provides additional insight into the factors that govern the discoloration of protein therapeutics and the role of AGEs in color change.

39. Navigating Patient Access Challenges In Commercializing Your CGT Product 3/10/2025

    Learn how to effectively break down barriers to patient access in cell and gene therapy by enhancing provider education, streamlining coordination, and expanding patient support.

40. Automated Bioprocessing To Enhance CAR T Cell Therapy Manufacturing 7/28/2025

    Automated bioprocessing can significantly improve CAR T cell manufacturing by reducing errors and enhancing scalability. Explore how this approach supports consistent, high-quality cell therapy production.